NCT06842810View on ClinicalTrials.gov

Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus

Not yet recruitingOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

December 31, 2027

Conditions
Systemic Lupus Erthematosus
Interventions
DIAGNOSTIC_TEST

Serum FGF21 measurement by Enzyme- linked immunosorbent assay (ELISA)

Venous 5 ml blood will be collected, then centrifugation at the speed of 2000-3000 rpm for 20-min., supernatant will be collected and stored at -20°C for later analysis then tha sample will be tested for fibroblast growth factor 21

All Listed Sponsors
lead

Assiut University

OTHER

NCT06842810 - Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter